| Bioactivity | Acetylleucine (N-Acetyl-DL-leucine), orally active compound, can be used for the research of acute vestibular vertigo, cerebellar ataxia and nystagmus[1][2]. | ||||||||||||
| Name | Acetylleucine | ||||||||||||
| CAS | 99-15-0 | ||||||||||||
| Formula | C8H15NO3 | ||||||||||||
| Molar Mass | 173.21 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Feil K, et, al. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus. Cerebellum. 2016 Feb;15(1):38-42. [2]. Clément G, et, al. Effects of vestibular training on motion sickness, nystagmus, and subjective vertical. J Vestib Res. 2007;17(5-6):227-37. |
Acetylleucine
CAS: 99-15-0 F: C8H15NO3 W: 173.21
Acetylleucine (N-Acetyl-DL-leucine), orally active compound, can be used for the research of acute vestibular vertigo, c
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.